Moore, Bethany B.

Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Collard, H. R., Moore, B. B., Flaherty, K. R., Brown, K. K., Kaner, R. J., King, T. E., Lasky, J. A., Loyd, J. E., Noth, I., Olman, M. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 1,130

Acellular Normal and Fibrotic Human Lung Matrices as a Culture System for In Vitro Investigation

Booth, A. J., Hadley, R., Cornett, A. M., Dreffs, A. A., Matthes, S. A., Tsui, J. L., Weiss, K., Horowitz, J. C., Fiore, V. F., Barker, T. H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine

Tissue Engineering and Regenerative MedicineInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 665

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease

O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology

Chronic Obstructive Pulmonary Disease (COPD) ResearchGut microbiota and health

Cited by 362

An essential role for fibronectin extra type III domain A in pulmonary fibrosis

Muro, A. F., Moretti, F. A., Moore, B. B., Yan, M., Atrasz, R. G., Wilke, C. A., Flaherty, K. R., Martinez, F. J., Tsui, J. L., Sheppard, D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments

Cited by 297

Prostaglandin E2 Inhibits Fibroblast to Myofibroblast Transition via E. Prostanoid Receptor 2 Signaling and Cyclic Adenosine Monophosphate Elevation

Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B. (2003) · American Journal of Respiratory Cell and Molecular Biology

Inflammatory mediators and NSAID effectsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 294

Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias

White, E. S., Xia, M., Murray, S., Dyal, R., Flaherty, C. M., Flaherty, K. R., Moore, B. B., Cheng, L., Doyle, T. J., Villalba, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 180

GM-CSF Regulates Bleomycin-Induced Pulmonary Fibrosis Via a Prostaglandin-Dependent Mechanism

Moore, B. B., Coffey, M. J., Christensen, P., Sitterding, S., Ngan, R., Wilke, C. A., McDonald, R., Phare, S. M., Peters-Golden, M., Paine, R., et al. (2000) · The Journal of Immunology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and Outcomes

Cited by 158

Prostaglandin E 2 as a Regulator of Immunity to Pathogens

Martínez-Colón, G. J., & Moore, B. B. (2018) · Pharmacology & Therapeutics

Inflammatory mediators and NSAID effectsImmune Response and Inflammation

Cited by 109

SKiM-GPT: combining biomedical literature-based discovery with large language model hypothesis evaluation

Freeman, J., Millikin, R. J., Xu, L., Sharma, I., Moore, B., Lock, C., Shine George, K., Bal, A., Mohanty, C., & Stewart, R. (2025) · BMC Bioinformatics

Biomedical Text Mining and OntologiesTopic Modeling

Cited by 4